Nabumetone Tablet
Product Images NDC 60760-369

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 60760-369). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nab (Nabumetone 60760 369 14)

Nab (Nabumetone 60760 369 14)
This is a medicine containing nabumetone in 750mg strength. It is in the form of tablets manufactured by ScieGen Pharmaceuticals Inc. and packaged by St. Mary's Pharmacy Programs. It has an NDC code of 60760-369-14 and is recommended to be stored at a temperature of 15-30°C.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
This is a graph showing the plasma concentrations of Nabumetone active metabolite (BMNA) at steady state following once-daily dosing of Nabumetone at 1000 mg and 2000 mg. The graph includes data points at 2.5D, 2D, 8D, and 42.5D (1000 mg) and 2D and 42.5D (2000 mg) and shows concentrations over time in hours.*
FDA Label Image

Structure1 (Structure1)

FDA Label Image

Structure2 (Structure2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.